NEOG Form 4: 19,769 shares granted; options expiring 2035

Rhea-AI Filing Summary

Neogen Corp (NEOG) reported an insider equity transaction. A director acquired 19,769 shares of common stock at $6.07 on 10/23/2025 (Transaction Code A). Following this, the director beneficially owned 34,621 common shares directly.

The filing also reports a grant of options to purchase 50,814 shares at an exercise price of $6.07, expiring on 10/23/2035. After the transactions, the director held 50,814 options. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Green Ronald D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock (Right to Buy)	50,814	$0.00	--
Grant/Award	Common Stock	19,769	$6.07	$120K

Holdings After Transaction: Common Stock (Right to Buy) — 50,814 shares (Direct); Common Stock — 34,621 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Green Ronald D

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/23/2025		A		19,769(1)	A	$6.07	34,621	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (Right to Buy)	$6.07	10/23/2025		A		50,814		(1)	10/23/2035	Common Stock	50,814	$0	50,814	D

Explanation of Responses:

1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

	Christopher Sefcheck (Attorney in Fact)	10/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NEOG report on Form 4?

A director acquired 19,769 common shares at $6.07 on 10/23/2025 and received options for 50,814 shares at $6.07.

How many NEOG shares does the insider hold after the transaction?

The insider beneficially owned 34,621 common shares directly after the reported transaction.

What are the terms of the NEOG stock options granted?

The options cover 50,814 shares at an exercise price of $6.07 and expire on 10/23/2035.

What is the vesting schedule for the NEOG awards?

The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.

Does the filing indicate the use of a Rule 10b5-1 trading plan?

The form includes a 10b5-1 checkbox option, but the excerpt does not indicate it was selected.

What is the reporting person’s relationship to NEOG?

The reporting person is a Director of Neogen Corp.